Yin-Cheng Lo

Title: The Innovative Contributions of Yin-Cheng Lo

Introduction

Yin-Cheng Lo is a notable inventor based in Green Oaks, Illinois, recognized for his significant contributions to the field of renal therapy. With a focus on improving patient outcomes during hemodialysis, Lo has developed innovative methods that enhance the prediction and optimization of serum potassium levels in patients undergoing treatment.

Latest Patents

Yin-Cheng Lo holds a patent for a method titled "Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis." This patent outlines a process for predicting serum potassium concentrations in patients during hemodialysis. The method involves measuring serum potassium levels throughout a treatment session and calculating an ultrafiltration rate based on the patient's body weight before and after dialysis. By estimating potassium mobilization clearance and pre-dialysis distribution volume, the method allows for accurate predictions of potassium concentrations at any point during treatment.

Career Highlights

Throughout his career, Yin-Cheng Lo has worked with prominent companies in the healthcare sector, including Baxter International Inc. and Baxter Healthcare. His experience in these organizations has contributed to his expertise in renal therapies and patient care.

Collaborations

Yin-Cheng Lo has collaborated with esteemed colleagues, including Alp Akonur and John Kenneth Leypoldt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of renal therapy.

Conclusion

Yin-Cheng Lo's work exemplifies the impact of innovative thinking in healthcare, particularly in the management of renal failure. His patented methods for predicting serum potassium levels represent a significant advancement in hemodialysis treatment, ultimately improving patient care and outcomes.